mda-mb-468-gfp

MDA-MB-468
from AcceGen
ABC-TC0657 | 1 vial: Ask for price
Description: The MDA-MB-468 cell line was isolated in 1977 by R. Cailleau, et al., From a pleural effusion of a 51-year-old Black female patient with metastatic adenocarcinoma of the breast.
MDA-MB-468 cells
from Addexbio
C0006003 | One Frozen vial: 546.00 EUR
MDA-MB-468 Cell Line
from Elabscience Biotech
CL-0290 | 1×10⁶ cells/vial: 420.00 EUR
Description: Homo sapiens, Human
GFP-Human MDA-MB-435(MDA-MB-435)
from AcceGen
ABC-RC211D | 1 vial: Ask for price
Description: Human MDA-MB-435 is a cell line isolated from the pleural effusion of a 31 year old female with metastatic, ductal adenocarcinoma of the breast. GFP-expressing MDA-MB-435 (GFP-MDA-MB-435) are selected from MDA-MB-435 cells after infected with lentiviruses expressing GFP with puromycin. The cells are shipped in a frozen vial with more than 5 x 105 cells/vial. Universal Full Growth Medium is recommended for cell culture and these cells have an average minimum population doubling levels > 20 when cultured following the detailed protocol described below.
MDA-MB-436
from Addexbio
C0006032 | One Frozen vial: 546.00 EUR
MDA-MB-157
from AcceGen
ABC-TC0649 | 1 vial: Ask for price
Description: The cells express the WNT7B oncogene. Desmosomes, microvilli and tonofilaments were observed at boundaries between cells.
MDA-MB-231
from AcceGen
ABC-TC0651 | 1 vial: Ask for price
Description: Species: human, Caucasian female 51 years old; Tissue: breast; Tumor: adenocarcinoma; Derived from: pleural effusion.
MDA-MB-361
from AcceGen
ABC-TC0652 | 1 vial: Ask for price
Description: This line differs from others of the series in karyology and in that it was isolated from a brain metastasis.
MDA-MB-415
from AcceGen
ABC-TC0653 | 1 vial: Ask for price
Description: The cells express the WNT7B oncogene. The patient presenting with the tumor was from Paraguay and, although listed as Caucasian, may have had mixed ancestry as suggested by the presence of G6PD type A phenotype in the cells.
MDA-MB-436
from AcceGen
ABC-TC0655 | 1 vial: Ask for price
Description: The line is pleomorphic and most cells react intensely with anti tubulin antibody as demonstrated by indirect immunofluorescence staining.
MDA-MB-453
from AcceGen
ABC-TC0656 | 1 vial: Ask for price
Description: MDA-MB-453 was derived in 1976 by R. Cailleau et al. From an effusion of a 48 year old female patient with metastatic carcinoma of the breast, involving the nodes, brain and both pleural and pericardial cavities.The cells overexpress FGF receptors.
MDA-MB-361
from Addexbio
C0006051 | One Frozen vial: 500.00 EUR
MDA-MB-435S
from AcceGen
ABC-TC0654 | 1 vial: Ask for price
Description: MDA-MB-435S is a spindle shaped strain which evolved from the parent line (435) isolated in 1976 (R. Cailleau et al.) From the pleural effusion of a 31 year old female with metastatic ductal adenocarcinoma of the breast.
MDA-MB-134-VI
from AcceGen
ABC-TC0648 | 1 vial: Ask for price
Description: This is one of a series of breast tumor lines isolated from pleural effusions and characterized by R. Cailleau and associates in 1973. The cells grow a monolayer of round loosely adherent cells.
MDA-MB-231 cells
from Addexbio
C0006002 | One Frozen vial: 546.00 EUR
MDA-MB-157 cells
from Addexbio
C0006020 | One Frozen vial: 546.00 EUR
MDA-MB-175-VII
from AcceGen
ABC-TC0650 | 1 vial: Ask for price
Description: This is one of a series of breast tumor lines isolated from pleural effusions and characterized by R. Cailleau and associates in 1973. The cells grow a monolayer of round loosely adherent cells.
MDA-MB-175VII cells
from Addexbio
C0006009 | One Frozen vial: 582.00 EUR
MDA-MB-231 Cell Line
from Elabscience Biotech
CL-0150 | 1×10⁶ cells/vial: 420.00 EUR
Description: Homo sapiens, Human
MDA-MB-453 Cell Line
from Elabscience Biotech
CL-0152 | 1×10⁶ cells/vial: 420.00 EUR
Description: Homo sapiens, Human
MDA-MB-415 Cell Line
from Elabscience Biotech
CL-0382 | 1×10⁶ cells/vial: 500.00 EUR
Description: Homo sapiens, Human
MDA-MB-436 Cell Line
from Elabscience Biotech
CL-0383 | 1×10⁶ cells/vial: 500.00 EUR
Description: Homo sapiens, Human
MDA-MB-361 Cell Line
from Elabscience Biotech
CL-0553 | 1×10⁶ cells/vial: 500.00 EUR
Description: Homo sapiens, Human
MDA-MB-175VII Cell Line
from Elabscience Biotech
CL-0381 | 1×10⁶ cells/vial: 500.00 EUR
Description: Homo sapiens, Human
Human MDA-MB-361 Cell Lysate
from Innovative research
IHUMDAMB361TL100UG | each: 245.00 EUR
Description: Human MDA-MB-361 Cell Lysate
OCPB00165-100UG - MDA-MB-361 Lysate
from Aviva Systems Biology
OCPB00165-100UG | 0.1mg: 139.00 EUR
CRISPRa (SAM) MDA-MB-231 Cell Line
from BPS Bioscience
78521 | 2 vials: 2500.00 EUR
Description: This cell line has been engineered for use with the CRISPR Synergistic Activation Mediator (SAM) system to induce transcriptional activation and expression of any gene of interest. Cells stably express a mutated dCas9 (Streptococcus pyogenes CRISPR-associated protein 9), lacking any endonuclease activity, fused to VP64, a transcriptional activator. Stable dCas9-VP64 expression is maintained with Blasticidin resistance. Cells also stably express a construct consisting of P65 (Transcription Factor p65, or Nuclear Factor NF-κB p65) and HSF1 (Heat Shock Factor 1) fused with an MS2 tag (from the MS2 coat protein), which is maintained with Hygromycin resistance. When these cells are transfected with an MS2 aptamer fused to a single guide RNA (sgRNA)targeting the promoter region of the gene of interest, dCas9-VP64 and MS2-P65-HSF1 are recruited to the promoter in the genomic DNA by the MS2 aptamer and begin transcription, inducing high level expression of the desired protein._x000D_Cells were functionally validated by transfecting the cells with an sgRNA-MS2 targeting PD-1, resulting in high expression of PD-1.
MDA-MB-231 / TetR (Puro) stable cells
from GenTarget
SC040-TetR | 2 x 106 cell/ml x 1ml: 1452.00 EUR
Description: Tetracycline repressor expression stable cell line with Puromycin marker in MDA-MB-231 human breast cancer cells.
Human MDA-MB-435S Whole Cell Lysate
from Innovative research
IHUMDAMB435STLW500UG | each: 327.00 EUR
Description: Human MDA-MB-435S Whole Cell Lysate
Cas9-Expressing MDA-MB-231 cell pool
from BPS Bioscience
78069 | 2 million cells: 795.00 EUR
Description: Cas9 (Streptococcus pyogenes CRISPR associated protein 9) is an endonuclease enzyme that, when recruited to a specific DNA sequence by the sgRNA (single guide RNA), introduces a double stranded break into the DNA. This double stranded break is repaired in mammalian cells either through Non-Homologous End Joining or Homologous Recombination. Non-Homologous End Joining often results in the deletion or insertion of several base pairs at the cut site, which, when resulting in a frameshift, causes the functional inactivation of the targeted gene. Cas9-expressing MDA-MB-231 cells can be transduced or electroporated with sgRNA targeting a gene of interest to quickly generate knock-out cell pools or cell lines.
Human MDA-MB-435S Cell Lysate Lyophilized
from Innovative research
IHUMDAMB435STLLY200UG | each: 89.00 EUR
Description: Human MDA-MB-435S Cell Lysate Lyophilized
Human MDA-MB-361 (Breast Adenocarcinoma) lysate
from Alpha Diagnostics
HCL-1217 | 100ug: 285.60 EUR
MDA-MB-231 / GFP (Bsd) Stable Cell Line
from GenTarget
SC040-Bsd | 2 x 106 cell/ml x 1ml: 1452.00 EUR
Description: GFP expression stable cell line in MDA-MB-231 cells with Blasticidin resistance
MDA-MB-231 / RFP (Bsd) Stable Cell Line
from GenTarget
SC057-Bsd | 2 x 106 cell/ml x 1ml: 1452.00 EUR
Description: RFP expression stable cell line in MDA-MB-231 cells with Blasticidin resistance
MDA-MB-231 / GFP (Puro) Stable Cell Line
from GenTarget
SC040-Puro | 2 x 106 cell/ml x 1ml: 1452.00 EUR
Description: GFP expression stable cell line in MDA-MB-231 cells with Puromycin resistance
MDA-MB-231 / Luciferase (Bsd) Stable Cell Line
from GenTarget
SC059-Bsd | 2 x 106 cell/ml x 1ml: 1800.00 EUR
Description: Luciferase (firefly) expression stable cell line in MDA-MB-231 cells with Blasticidin resistance
GFP-Human MDA-MB-231 Breast Cancer Cells
from AcceGen
ABC-RC207D | 1 vial: Ask for price
Description: Human MDA-MB-231 is a human adenocarcinoma cells derived from 51 year old (Caucasian) patient metastatic site. MDA-MB-231 are adherent epithelial like cells when culture with DMEM full medium containing 10% FBS. GFP-MDA-MB-231 cells are selected from puromycin resistant MDA-MB-231 after infected with GFP Expressing lentiviral particles. The cells are shipped in proliferating culture with >90 confluence or in a frozen vial with > 1.0 x 106cells/vial.
RFP-Human MDA-MB-231 Breast Cancer Cells
from AcceGen
ABC-RC208D | 1 vial: Ask for price
Description: Human MDA-MB-231 is a human adenocarcinoma cells derived from 51 year old (Caucasian) patient metastatic site. MDA-MB-231 are adherent epithelial like cells when culture with DMEM full medium containing 10% FBS. RFP-MDA-MB-231 cells are selected from Zeocin resistant MDA-MB-231 cells after infected with RFP expressing lentiviral particles. The cells are shipped in proliferating culture with >90 confluence or in a frozen vial with > 1.0 x 106cells/vial.
MDA-MB-231 / Luciferase (Puro) Stable Cell Line
from GenTarget
SC059-Puro | 2 x 106 cell/ml x 1ml: 1800.00 EUR
Description: Luciferase (firefly) expression stable cell line in MDA-MB-231 cells with Puromycin resistance
OCRA00105-500UG - MDA-MB-435S Whole Cell Lysate
from Aviva Systems Biology
OCRA00105-500UG | 500ug: 189.00 EUR
MDA-MB-231 / Luciferase-2A-RFP Stable Cell Line
from GenTarget
SC041 | 2 x 106 cell/ml x 1ml: 2670.00 EUR
Description: Firefly luciferase and GFP co-expression stable cell line in MDA-MB-231 cells with Blasticidin resistance
MDA-MB-231 / Luciferase-2A-GFP Stable Cell Line
from GenTarget
SC044 | 2 x 106 cell/ml x 1ml: 2670.00 EUR
Description: Luciferase (firefry) and GFP co-expression stable cell line in MDA-MB-231 human breast cancer cell line with Puromycin marker.
Human NFkB Luciferase Reporter Cell Line- MDA-MB-231
from AcceGen
ABC-RC0026 | 1 vial: Ask for price
Description: Human NFkB Luciferase Reporter Cell Line- MDA-MB-231 is derived from Human breast cancer, and stably express firefly luciferase reporter gene under the control of NFkB response element. This cell line is an ideal cellular model for monitoring the activation of NFkB response Pathway triggered by stimuli treatment, enforced gene expression and gene knockdown.
MDA 19
from MedChemExpress
HY-15451 | 5mg: 151.20 EUR
MDA-kb2
from AcceGen
ABC-TC0647 | 1 vial: Ask for price
Description: Since both glucocorticoid receptor and androgen receptor are present in the MDA-MB-453 cells, and both receptors can act through the MMTV promoter, compounds that act through either androgen receptor or glucocorticoid receptor activate the MMTV luciferase.
Cas9-Expressing MDA-MB-231 Cell Line (High or Low Expression)-78150-H
from BPS Bioscience
78150-H | 2 vials: 6500.00 EUR
Description: This cell line is a clonal derivative from the Cas9-Expressing MDA-MB-231 Cell Pool (BPS Bioscience, #78069). It was generated by limited limiting dilution of the original pool and isolation of individual clones, which were screened based on Cas9 expression to obtain a low- or high-expressing cell line. The expressed Cas9 protein includes a C-terminal FLAG tag.
Cas9-Expressing MDA-MB-231 Cell Line (High or Low Expression)-78150-L
from BPS Bioscience
78150-L | 2 vials: 6500.00 EUR
Description: This cell line is a clonal derivative from the Cas9-Expressing MDA-MB-231 Cell Pool (BPS Bioscience, #78069). It was generated by limited limiting dilution of the original pool and isolation of individual clones, which were screened based on Cas9 expression to obtain a low- or high-expressing cell line. The expressed Cas9 protein includes a C-terminal FLAG tag.
MDA-5 Antibody
from NSJ Bioreagents
R35986-100UG | 100 ug: 339.15 EUR
Description: Additional name(s) for this target protein: Melanoma differentiation associated protein-5, IFIH1, interferon induced with helicase C domain 1
MDA Assay Kit
from Fitzgerald
55R-1512 | 100 assays: 970.80 EUR
Description: Assay Kit for detection of MDA in the research laboratory
Human MDA ELISA
from Kamiya Biomedical Company
KT-53246 | 96 tests: 1013.00 EUR
MDA Adduct ELISA
from Kamiya Biomedical Company
KT-956 | 96 tests: 864.00 EUR
MDA-BSA Control
from Cell Biolabs
STA-333 | 100 µg: 386.40 EUR
Description:
  • MDA-BSA (Malondialdehyde-BSA) may be used as a positive control. 100 µg.
  • Provided at 1 mg/mL in 1X PBS
Malondialdehyde (MDA) (HSA)
from Abbexa
20-abx281005 | [ 100 ug: 693.60 EUR ] [ 10 ug: 309.60 EUR ] [ 1 mg: 2064.00 EUR ] [ 200 ug: 828.00 EUR ] [ 50 ug: 510.00 EUR ]
Malondialdehyde (MDA) ELISA
from Kamiya Biomedical Company
KT-21493 | 96 tests: 1032.00 EUR
MDA-7 Rabbit pAb
from EnoGene
E2251680 | 100ul: 225.00 EUR
Description: Available in various conjugation types.
Malondialdehyde (MDA) Antibody
from Abbexa
abx023266-1ml | 1 ml: 678.00 EUR
Malondialdehyde (MDA) Antibody
from Abbexa
20-abx130475 | [ 100 ug: 477.60 EUR ] [ 10 ug: 159.60 EUR ] [ 1 mg: 1296.00 EUR ] [ 200 ug: 644.40 EUR ] [ 50 ug: 360.00 EUR ]
CD14(MDA/929) Antibody
from Biotium
BNC800929-100 | 100uL: 238.80 EUR
Description: Primary antibody against CD14(MDA/929), CF680 conjugate, Concentration: 0.1mg/mL
CD14(MDA/929) Antibody
from Biotium
BNC800929-500 | 500uL: 652.80 EUR
Description: Primary antibody against CD14(MDA/929), CF680 conjugate, Concentration: 0.1mg/mL
CD14(MDA/929) Antibody
from Biotium
BNC810929-100 | 100uL: 238.80 EUR
Description: Primary antibody against CD14(MDA/929), CF680R conjugate, Concentration: 0.1mg/mL
CD14(MDA/929) Antibody
from Biotium
BNC810929-500 | 500uL: 652.80 EUR
Description: Primary antibody against CD14(MDA/929), CF680R conjugate, Concentration: 0.1mg/mL
CD14(MDA/929) Antibody
from Biotium
BNC940929-100 | 100uL: 238.80 EUR
Description: Primary antibody against CD14(MDA/929), CF594 conjugate, Concentration: 0.1mg/mL
CD14(MDA/929) Antibody
from Biotium
BNC940929-500 | 500uL: 652.80 EUR
Description: Primary antibody against CD14(MDA/929), CF594 conjugate, Concentration: 0.1mg/mL
CD14(MDA/929) Antibody
from Biotium
BNC700929-100 | 100uL: 238.80 EUR
Description: Primary antibody against CD14(MDA/929), CF770 conjugate, Concentration: 0.1mg/mL
CD14(MDA/929) Antibody
from Biotium
BNC700929-500 | 500uL: 652.80 EUR
Description: Primary antibody against CD14(MDA/929), CF770 conjugate, Concentration: 0.1mg/mL
CD14(MDA/929) Antibody
from Biotium
BNC880929-100 | 100uL: 238.80 EUR
Description: Primary antibody against CD14(MDA/929), CF488A conjugate, Concentration: 0.1mg/mL
CD14(MDA/929) Antibody
from Biotium
BNC880929-500 | 500uL: 652.80 EUR
Description: Primary antibody against CD14(MDA/929), CF488A conjugate, Concentration: 0.1mg/mL
CD14(MDA/929) Antibody
from Biotium
BNC050929-100 | 100uL: 238.80 EUR
Description: Primary antibody against CD14(MDA/929), CF405M conjugate, Concentration: 0.1mg/mL
CD14(MDA/929) Antibody
from Biotium
BNC050929-500 | 500uL: 652.80 EUR
Description: Primary antibody against CD14(MDA/929), CF405M conjugate, Concentration: 0.1mg/mL
CD14(MDA/929) Antibody
from Biotium
BNC040929-100 | 100uL: 238.80 EUR
Description: Primary antibody against CD14(MDA/929), CF405S conjugate, Concentration: 0.1mg/mL
CD14(MDA/929) Antibody
from Biotium
BNC040929-500 | 500uL: 652.80 EUR
Description: Primary antibody against CD14(MDA/929), CF405S conjugate, Concentration: 0.1mg/mL
CD14(MDA/929) Antibody
from Biotium
BNC400929-100 | 100uL: 238.80 EUR
Description: Primary antibody against CD14(MDA/929), CF640R conjugate, Concentration: 0.1mg/mL
CD14(MDA/929) Antibody
from Biotium
BNC400929-500 | 500uL: 652.80 EUR
Description: Primary antibody against CD14(MDA/929), CF640R conjugate, Concentration: 0.1mg/mL
CD14(MDA/929) Antibody
from Biotium
BNCB0929-100 | 100uL: 238.80 EUR
Description: Primary antibody against CD14(MDA/929), Biotin conjugate, Concentration: 0.1mg/mL
CD14(MDA/929) Antibody
from Biotium
BNCB0929-500 | 500uL: 652.80 EUR
Description: Primary antibody against CD14(MDA/929), Biotin conjugate, Concentration: 0.1mg/mL
CD14(MDA/929) Antibody
from Biotium
BNCAP0929-100 | 100uL: 238.80 EUR
Description: Primary antibody against CD14(MDA/929), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL
CD14(MDA/929) Antibody
from Biotium
BNCAP0929-500 | 500uL: 652.80 EUR
Description: Primary antibody against CD14(MDA/929), Alkaline Phosphatase conjugate, Concentration: 0.1mg/mL
CD14(MDA/929) Antibody
from Biotium
BNCA0929-250 | 250uL: 459.60 EUR
Description: Primary antibody against CD14(MDA/929), APC conjugate, Concentration: 0.1mg/mL
CD14(MDA/929) Antibody
from Biotium
BNCR0929-250 | 250uL: 459.60 EUR
Description: Primary antibody against CD14(MDA/929), RPE conjugate, Concentration: 0.1mg/mL
CD14(MDA/929) Antibody
from Biotium
BNCP0929-250 | 250uL: 459.60 EUR
Description: Primary antibody against CD14(MDA/929), PerCP conjugate, Concentration: 0.1mg/mL
CD14(MDA/929) Antibody
from Biotium
BNUM0929-50 | 50uL: 474.00 EUR
Description: Primary antibody against CD14(MDA/929), 1mg/mL
CD14(MDA/929) Antibody
from Biotium
BNCH0929-100 | 100uL: 238.80 EUR
Description: Primary antibody against CD14(MDA/929), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL
CD14(MDA/929) Antibody
from Biotium
BNCH0929-500 | 500uL: 652.80 EUR
Description: Primary antibody against CD14(MDA/929), Horseradish Peroxidase conjugate, Concentration: 0.1mg/mL
CD14(MDA/929) Antibody
from Biotium
BNUB0929-100 | 100uL: 250.80 EUR
Description: Primary antibody against CD14(MDA/929), Concentration: 0.2mg/mL
CD14(MDA/929) Antibody
from Biotium
BNUB0929-500 | 500uL: 549.60 EUR
Description: Primary antibody against CD14(MDA/929), Concentration: 0.2mg/mL
CD14(MDA/929) Antibody
from Biotium
BNC610929-100 | 100uL: 238.80 EUR
Description: Primary antibody against CD14(MDA/929), CF660R conjugate, Concentration: 0.1mg/mL
CD14(MDA/929) Antibody
from Biotium
BNC610929-500 | 500uL: 652.80 EUR
Description: Primary antibody against CD14(MDA/929), CF660R conjugate, Concentration: 0.1mg/mL
CD14(MDA/929) Antibody
from Biotium
BNC550929-100 | 100uL: 238.80 EUR
Description: Primary antibody against CD14(MDA/929), CF555 conjugate, Concentration: 0.1mg/mL
<